297 reports of this reaction
2.1% of all DESONIDE reports
#9 most reported adverse reaction
RASH is the #9 most commonly reported adverse reaction for DESONIDE, manufactured by Actavis Pharma, Inc.. There are 297 FDA adverse event reports linking DESONIDE to RASH. This represents approximately 2.1% of all 14,012 adverse event reports for this drug.
Patients taking DESONIDE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for DESONIDE, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for DESONIDE:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 297 FDA reports for DESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 2.1% of all adverse event reports for DESONIDE, making it a notable side effect.
If you experience rash while taking DESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.